A randomized phase II study of Pemetrexed plus Carboplatin followed by Pemetrexed versus Paclitaxel plus Carboplatin followed by Pemetrexed in patients with chemotherapy naïve non-squamous non-small cell lung cancer.
Phase 2
- Conditions
- Chemotherapy na&iumlve non-squamous non-small cell lung cancer
- Registration Number
- JPRN-UMIN000005008
- Lead Sponsor
- ung Oncology Group in Kyushu, Japan (LOGIK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
Severe complicaiton including heart disease, pulmonary fibrosis, bleeding tendency, uncontrollable hypertension and diabetes mellitus. Patients with symptomatic brain metastasis. Active concomitant malignancy. Past history of drug hypersensitivity. Psychiatric disorder. Systemic steroid administration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression Free Survival
- Secondary Outcome Measures
Name Time Method